Eversept Partners, LP
- SEC CIK
- 0001697013
- 最新申報
- 2026/8/14
2024 年第 4 季持倉
持倉截至 2024/12/31，2025/2/14 申報。只含多頭部位，變化是跟 2024 年第 3 季比股數。
- 持股檔數
- 62
- 較 2024 年第 3 季 −3
- 總值
- $9.69 億
- 較 2024 年第 3 季 −$3.35 億 (−25.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| NTRANatera, Inc. | COM | 876,766 | $1.39 億 | 14.3% | +6,573+0.8% | 加碼 | 歷史 |
| GSKGSK plc | ADR | 3,661,768 | $1.24 億 | 12.8% | −395,438−9.7% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 1,600,015 | $6,766 萬 | 7.0% | −450,142−22.0% | 減碼 | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 294,302 | $5,456 萬 | 5.6% | +18,032+6.5% | 加碼 | 歷史 |
| HCAHCA Healthcare, Inc. | COM | 175,808 | $5,277 萬 | 5.4% | +46,724+36.2% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 2,242,125 | $4,942 萬 | 5.1% | −992,513−30.7% | 減碼 | 歷史 |
| RVTYRevvity, Inc. | COM | 392,518 | $4,381 萬 | 4.5% | −77,174−16.4% | 減碼 | 歷史 |
| HQYHealthequity, Inc. | COM | 386,697 | $3,710 萬 | 3.8% | +67,619+21.2% | 加碼 | 歷史 |
| ZIMVZimVie Inc. | Stock | 2,070,780 | $2,889 萬 | 3.0% | 00.0% | 不變 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 678,787 | $2,620 萬 | 2.7% | +233,583+52.5% | 加碼 | 歷史 |
| TECHBIO-TECHNE Corp | COM | 299,310 | $2,156 萬 | 2.2% | −364,263−54.9% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 719,836 | $1,819 萬 | 1.9% | +154,934+27.4% | 加碼 | 歷史 |
| VTRSViatris Inc | Stock | 1,272,102 | $1,584 萬 | 1.6% | −454,252−26.3% | 減碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 43,703 | $1,542 萬 | 1.6% | −87,246−66.6% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 779,998 | $1,495 萬 | 1.5% | +88,766+12.8% | 加碼 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 1,980,312 | $1,489 萬 | 1.5% | +1,444,907+269.9% | 加碼 | 歷史 |
| BRKRBruker Corp | COM | 234,934 | $1,377 萬 | 1.4% | +234,934 | 新進 | 歷史 |
| EWEdwards Lifesciences Corp | Stock | 170,678 | $1,264 萬 | 1.3% | +170,678 | 新進 | 歷史 |
| DXCMDexcom Inc | COM | 148,688 | $1,156 萬 | 1.2% | +148,688 | 新進 | 歷史 |
| CNCCentene Corp | Stock | 188,493 | $1,142 萬 | 1.2% | +53,534+39.7% | 加碼 | 歷史 |
| TFXTeleflex Inc | COM | 61,736 | $1,099 萬 | 1.1% | +61,736 | 新進 | 歷史 |
| ELVElevance Health, Inc. | Stock | 29,178 | $1,076 萬 | 1.1% | +9,713+49.9% | 加碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 127,588 | $1,044 萬 | 1.1% | +127,588 | 新進 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 490,296 | $854.1 萬 | 0.9% | −379,617−43.6% | 減碼 | 歷史 |
| CYHCommunity Health Systems Inc | COM | 2,827,000 | $845.3 萬 | 0.9% | −5,949,455−67.8% | 減碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 276,036 | $843.3 萬 | 0.9% | +276,036 | 新進 | 歷史 |
| RGENRepligen Corp | COM | 54,066 | $778.2 萬 | 0.8% | −109,527−67.0% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 214,952 | $751.5 萬 | 0.8% | −256,403−54.4% | 減碼 | 歷史 |
| FTREFortrea Holdings Inc. | COMMON STOCK | 401,733 | $749.2 萬 | 0.8% | −56,234−12.3% | 減碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 275,362 | $707.7 萬 | 0.7% | −31,995−10.4% | 減碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 102,661 | $672.6 萬 | 0.7% | +102,661 | 新進 | 歷史 |
| LQDALiquidia Corp | COM NEW | 571,305 | $671.9 萬 | 0.7% | +433,356+314.1% | 加碼 | 歷史 |
| MEDPMedpace Holdings, Inc. | COM | 19,049 | $632.9 萬 | 0.7% | +19,049 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 155,540 | $609.7 萬 | 0.6% | +155,540 | 新進 | 歷史 |
| MNKDMannkind Corp | COM NEW | 911,025 | $585.8 萬 | 0.6% | −1,081,479−54.3% | 減碼 | 歷史 |
| HUMHumana Inc | Stock | 22,682 | $575.5 萬 | 0.6% | −11,178−33.0% | 減碼 | 歷史 |
| HSICHenry Schein Inc | COM | 80,303 | $555.7 萬 | 0.6% | +80,303 | 新進 | 歷史 |
| DHRDanaher Corp | Stock | 22,209 | $509.8 萬 | 0.5% | −16,220−42.2% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 343,400 | $454.0 萬 | 0.5% | −3,761,913−91.6% | 減碼 | 歷史 |
| PDCOPatterson Companies, Inc. | COM | 146,051 | $450.7 萬 | 0.5% | +146,051 | 新進 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 4,978,458 | $450.4 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| EOLSEvolus, Inc. | COM | 383,045 | $422.9 萬 | 0.4% | −70,016−15.5% | 減碼 | 歷史 |
| ICLRIcon PLC | COM | 19,252 | $403.7 萬 | 0.4% | +5,584+40.9% | 加碼 | 歷史 |
| SUPNSupernus Pharmaceuticals, Inc. | COM | 105,581 | $381.8 萬 | 0.4% | +105,581 | 新進 | 歷史 |
| AVTRAvantor, Inc. | COM | 168,369 | $354.8 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 996,102 | $303.8 萬 | 0.3% | −297,155−23.0% | 減碼 | 歷史 |
| TSVT2seventy bio, Inc. | COMMON STOCK | 1,003,678 | $295.1 萬 | 0.3% | +5,599+0.6% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 68,258 | $287.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 777,890 | $272.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ZLABZai Lab Ltd | ADR | 102,930 | $269.6 萬 | 0.3% | −32,289−23.9% | 減碼 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 191,158 | $266.3 萬 | 0.3% | −502,105−72.4% | 減碼 | 歷史 |
| XRAYDentsply Sirona Inc. | Stock | 139,656 | $265.1 萬 | 0.3% | +139,656 | 新進 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 95,417 | $250.8 萬 | 0.3% | +1,128+1.2% | 加碼 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 220,196 | $169.1 萬 | 0.2% | +220,196 | 新進 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM | 2,088,757 | $141.3 萬 | 0.1% | −3,459,123−62.4% | 減碼 | 歷史 |
| ZBIOZenas BioPharma, Inc. | COM | 172,103 | $141.0 萬 | 0.1% | −18,428−9.7% | 減碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 694,408 | $127.8 萬 | 0.1% | −1,147,581−62.3% | 減碼 | 歷史 |
| IFRXInflaRx N.V. | COM | 492,452 | $121.6 萬 | 0.1% | −1,129,335−69.6% | 減碼 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 1,516,592 | $73.6 萬 | 0.1% | −1,792,717−54.2% | 減碼 | 歷史 |
| ABSIAbsci Corp | COM | 199,464 | $52.3 萬 | 0.1% | −73,405−26.9% | 減碼 | 歷史 |
| ALECAlector, Inc. | COM | 200,095 | $37.8 萬 | <0.1% | −132,661−39.9% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 98,895 | $23.2 萬 | <0.1% | −307,663−75.7% | 減碼 | 歷史 |
選擇權（3 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $1.24 億 | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $1,747 萬 | – |
| iShares Tr464287432 | 20 YR TR BD ETF | $1,567 萬 | – |
2024 年第 3 季之後清倉（17 檔）
2024 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 3 季股數 | 2024 年第 3 季市值 | 2024 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| INSMINSMED Inc | COM PAR $.01 | 1,089,404 | $7,953 萬 | 6.1% | 歷史 |
| BHCBausch Health Companies Inc. | Stock | 1,530,914 | $1,249 萬 | 1.0% | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 124,491 | $910.9 萬 | 0.7% | 歷史 |
| BHVNBiohaven Ltd. | COM | 132,537 | $662.3 萬 | 0.5% | 歷史 |
| BKDBrookdale Senior Living Inc. | COM | 861,268 | $584.8 萬 | 0.4% | 歷史 |
| FNAParagon 28, Inc. | COM | 749,213 | $500.5 萬 | 0.4% | 歷史 |
| KURAKura Oncology, Inc. | COM | 192,398 | $375.9 萬 | 0.3% | 歷史 |
| MOHMolina Healthcare, Inc. | COM | 10,588 | $364.8 萬 | 0.3% | 歷史 |
| STAAStaar Surgical Co | COM PAR $0.01 | 91,199 | $338.8 萬 | 0.3% | 歷史 |
| IQVIQVIA Holdings Inc. | Stock | 13,138 | $311.3 萬 | 0.2% | 歷史 |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 336,966 | $280.0 萬 | 0.2% | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 84,380 | $216.9 萬 | 0.2% | 歷史 |
| NVRONevro Corp | COM | 313,780 | $175.4 萬 | 0.1% | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 485,141 | $101.4 萬 | 0.1% | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 52,006 | $63.9 萬 | <0.1% | 歷史 |
| Affimed N VN01045207 | ORDINARY SHS NEW | 166,460 | $55.9 萬 | <0.1% | – |
| ACIUAC Immune SA | SHS | 99,313 | $37.5 萬 | <0.1% | 歷史 |